News
Dartmouth-Hitchcock Health Employees Inspire Historic Multi-Million Dollar Gift
Bill and Sue Conaty pledge $5.25 million in support of Dartmouth-Hitchcock Medical Center’s new Patient Pavilion
Researchers Find Source of Breast Tumor Heterogeneity and Pathway that Limits Emergence
Researchers find a signaling pathway that limits mammary basal cells’ ability to fuel the growth of multiple aggressive cell populations within a breast tumor, uncovering opportunities for novel therapeutic approaches to breast cancer.
Norris Cotton Cancer Center Launches New Cellular Therapy Program
NCCC treats the first patients with new CAR T-cell therapy.
Clinical Trial of Anti-VISTA Cancer Antibody Therapy Opens for Patient Enrollment
Dartmouth-Hitchcock Norris Cotton Cancer Center leads a new multi-center Phase I in-human clinical trial of anti-VISTA, a therapeutic antibody designed to target a molecule that keeps the immune system quiet against cancer.
New Grant Will Improve Rural Patient Access to Cancer Clinical Trials
A newly awarded $820,000 grant from The National Cancer Institute (NCI) will allow a team of investigators to increase clinical trial awareness and participation for rural patients.
Rapid Genomic Profiling of Colon Cancers can Improve Therapy Selection for Patients
Multicenter study led by NCCC shows vastly improved turnaround time to get results from the lab to the oncologist using the newest technology in the cancer testing space.
Dartmouth-Hitchcock Health Resumes Time-Sensitive, Urgent Procedures and Appointments
Health system laying important groundwork to begin process of recovery for benefit of patients
Base Camp COVID: Dartmouth-Hitchcock Health CEO and President Tours COVID-19 Unit
Joanne Conroy, MD, Visits the Medical Intensive Care Unit at Dartmouth-Hitchcock Medical Center
New AI Model Accurately Classifies Colorectal Polyps Using Slides from 24 Institutions
Dartmouth researchers have created an AI model to classify colorectal polyps on histology slides. Evaluation using 238 slides from 24 institutions across 13 US states finds that the model performs as well as practicing pathologists.
Discovering a Key to the Survival of Dormant Breast Cancer Cells
A common anti-diabetes drug being tested in many clinical trials as an anti-cancer agent activated fat metabolism that promoted the survival of dormant breast cancer cells, suggesting that the drug has context-dependent effects on cancer cells.